<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03919838</url>
  </required_header>
  <id_info>
    <org_study_id>KB/232/2016</org_study_id>
    <nct_id>NCT03919838</nct_id>
  </id_info>
  <brief_title>Effect of Probiotic on Oral Health of Children</brief_title>
  <official_title>Effect of Probiotic Lactobacillus Salivarius and Cranberry on Oral Health of Children</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medical University of Warsaw</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>NutroPharma</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Medical University of Warsaw</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of the randomized, double-blind clinical trial with placebo is to answer the clinical&#xD;
      question , or in children with diagnosed childhood early caries the use of L.salivarius and&#xD;
      cranberry contained in NutroPharma lozenges will reduce new carious lesions and reduce the&#xD;
      titre of the carcinogenic bacteria Streptococcus mutans, compared to the control group in&#xD;
      which the placebo will be administered? The main end point will be to reduce the titre of&#xD;
      cariogenic bacteria.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Probiotic bacteria are used in the prevention and treatment of gastrointestinal diseases and&#xD;
      infections, including the treatment of oral diseases. Probiotic bacteria can be found in&#xD;
      saliva, plaque and adhering directly to the mucous membrane. They compete with cariogenic&#xD;
      bacteria and pathogens of periodontal disease. Increased interest in probiotics means that&#xD;
      attempts are being made to find new solutions regarding the methods of their administration.&#xD;
      The use of probiotic bacteria brings beneficial health effects. Lactobacillus salivarius is a&#xD;
      strain isolated from human milk. It is inactive (heat treatment) and therefore does not&#xD;
      produce metabolites that can promote the formation of carious lesions in the mouth by&#xD;
      lowering the mouth potential of hydrogen.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date type="Actual">July 19, 2019</start_date>
  <completion_date type="Anticipated">December 2019</completion_date>
  <primary_completion_date type="Anticipated">December 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Parallel Assignment</intervention_model_description>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Triple (Participant, Care Provider, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Changing the titre of the carcinogenic bacteria Streptococcus mutans</measure>
    <time_frame>8 weeks</time_frame>
    <description>During control tests saliva will be applied to the medium for identification and detailed quantification of S. mutans bacteria. After the incubation, the number of bacteria will be expressed - taking into account the degree of saliva dilution - as the number of colony-forming unit (CFU) in 1 ml of saliva.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">80</enrollment>
  <condition>Oral Disease</condition>
  <arm_group>
    <arm_group_label>Probiotics</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Participants will receive two lozenges containing probiotic bacteria and cranberry.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo - No probiotics</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Participants will receive a control two lozenges containing no probiotic bacteria.</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Probiotics</intervention_name>
    <description>A half of the participants will be randomly allocated to the probiotics group. They will receive two probiotics lozenge before falling asleep for 8 weeks. Clinical examination will be conducted before study and after 8 weeks.</description>
    <arm_group_label>Probiotics</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Placebo - No probiotics</intervention_name>
    <description>A half of the participants will be randomly allocated to the placebo group. They will receive two no probiotics lozenge before falling asleep for 8 weeks. Clinical examination will be conducted before study and after 8 weeks.</description>
    <arm_group_label>Placebo - No probiotics</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  generally healthy children aged 3-6;&#xD;
&#xD;
          -  recognized caries of early childhood, dmf&gt; 1,&#xD;
&#xD;
          -  lack of active caries and inflammation of the mouth&#xD;
&#xD;
          -  colony forming unit CFU &gt; 105 / ml Streptococcus mutans&#xD;
&#xD;
          -  a minimum of one-month period from: the last antibiotic therapy, probiotic use,&#xD;
             professional fluoride prophylaxis or supervised tooth brushing with fluoride&#xD;
             preparations, the use of fluoride toothpaste, not using xylitol, written consent of&#xD;
             parents / legal guardians for participation in research.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  chronic diseases and chronically taken medicines in the past,&#xD;
&#xD;
          -  planned change of residence during the year,&#xD;
&#xD;
          -  age below 3 and above 6 years,&#xD;
&#xD;
          -  healthy teeth, dmf = 0,&#xD;
&#xD;
          -  colony forming unit CFU &lt;105 / ml Streptococcus mutans&#xD;
&#xD;
          -  Patient during antibiotic therapy, probiotic use, professional fluoride prophylaxis or&#xD;
             supervised tooth brushing with fluoride preparations&#xD;
&#xD;
          -  no toothpaste with fluoride&#xD;
&#xD;
          -  using xylitol&#xD;
&#xD;
          -  lack of written consent of parents / legal guardians for participation in research.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>3 Years</minimum_age>
    <maximum_age>6 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Dorota Olczak-Kowalczyk</name>
      <address>
        <city>Warsaw</city>
        <state>Warsaw, 18 Miodowa Saint</state>
        <zip>00-246</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dorota Olczak-Kowalczyk, Ass.Prof.</last_name>
      <phone>+48 22 502 20 31</phone>
      <email>pedodoncja@wum.edu.pl</email>
    </contact>
    <investigator>
      <last_name>Anna Turska-Szybka, Phd, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Dorota Olczak-Kowalczyk, Ass.Prof.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Poland</country>
  </location_countries>
  <verification_date>June 2019</verification_date>
  <study_first_submitted>April 15, 2019</study_first_submitted>
  <study_first_submitted_qc>April 17, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">April 18, 2019</study_first_posted>
  <last_update_submitted>October 30, 2019</last_update_submitted>
  <last_update_submitted_qc>October 30, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">October 31, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>probiotic</keyword>
  <keyword>oral health</keyword>
  <keyword>children</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Mouth Diseases</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

